Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20039320 20180850 1.84 96.9 null 2019-12-12 2019-12-19 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101592294
20040998 20180851 0 80.1 null 2016-05-24 2016-05-31 null 02 null CAPECITABINE + MITOMYCIN 101468702
20042790 20180852 0 null null 2016-09-11 2016-11-12 Fluorouracil+Mitomycin+RT (Anal Ca) 02 null FLUOROURACIL + MITOMYCIN 101117493
20047432 20180854 0 null null 2020-06-26 2020-11-23 null 02 null LANREOTIDE 101205070
20047460 20180855 1.63 null null 2019-01-10 2019-01-20 Cape+Cisplatin+Trastuzumab Main 02 null HCX 101234913
20048023 20180856 0 93.6 null 2018-10-16 2018-11-09 LENVATINIB 02 null LENVATINIB 100262178
20048993 20180857 0 90.1 null null null Doxorubicin chemoembolisation N null DOXORUBICIN EMBOLISATION 100973345
20050043 20180858 0 77 Palliative (P) 2016-09-17 2018-01-31 LANREOTIDE 02 N LANREOTIDE 100345266
20052484 20180859 0 61 null 2021-08-15 2021-08-16 LANREOTIDE 02 null LANREOTIDE 101022083
20052570 20180860 0 null null 2018-01-06 2018-01-07 LANREOTIDE 02 null LANREOTIDE 101319743
20053056 20180861 0 64.2 null 2019-01-19 2019-02-05 null 02 null FLUOROURACIL + MITOMYCIN 101457667
20062614 20180865 0 61.4 null null 2022-05-12 null 99 null LENVATINIB 101647803
20065637 20180866 0 75.3 null 2019-08-19 2019-09-25 OXALIPLATIN + MDG + PANITUMUMAB 02 null FLUOROURACIL + OXALIPLATIN + PANITUMUMAB 100222094
20069155 20180868 1.76 null Palliative (P) 2020-10-13 2020-11-06 LANREOTIDE 02 N LANREOTIDE 101117936
20073374 20180869 1.76 66.2 Palliative (P) null 2022-04-02 null null N CARBOPLATIN 101601864
20078310 20180870 1.7 58 Adjuvant (A) 2017-04-24 2017-04-26 null null N CAPECITABINE + CARBOPLATIN + EPIRUBICIN 100647413
20078460 20180871 1.71 70.8 null 2021-08-18 2021-08-30 Imatinib 400mg 02 null IMATINIB 100966912
20078985 20180872 1.67 78 Palliative (P) 2020-02-26 2020-02-27 null null N IMATINIB 100782911
20092372 20180873 1.93 80.2 null null 2021-10-16 REGORAFENIB 02 null REGORAFENIB 101615191
20111191 20180874 1.63 92.8 Palliative (P) null 2021-05-08 null null N PLATFORM TRIAL 100997276
20112751 20180875 1.74 57 null 2022-02-05 2022-02-05 null null null PLATFORM TRIAL 101260811
20121424 20180877 1.86 null Neo-adjuvant (N) 2020-06-14 2020-06-16 null null N CARBOPLATIN + GEMCITABINE 100191559
20122862 20180878 1.64 null null 2019-07-03 2019-08-18 null null null CARBOPLATIN 101168979
20124005 20180879 1.71 94 null 2020-04-22 2021-02-21 null null null CAPECITABINE + CARBOPLATIN + EPIRUBICIN 101570061
20124470 20180880 1.7 84 null 2021-02-23 2021-04-14 null null null CAPECITABINE + TEMOZOLOMIDE 100368605
20128425 20180881 1.65 0 03 2021-02-04 2021-02-23 null N N CISPLATIN + EPIRUBICIN + FLUOROURACIL 101186030
20133526 20180882 1.81 0 Adjuvant (A) null 2021-04-07 null 02 null CAPECITABINE + CISPLATIN + EPIRUBICIN 101369305
20134721 20180883 1.56 63.2 Palliative (P) null 2019-08-07 LU-177 null Y NOT MATCHED 100284389
20141745 20180884 1.81 67.2 Palliative (P) 2019-09-28 2019-12-17 null N N SUNITINIB 101465889
20142915 20180885 1.61 52.9 null 2022-04-26 2022-04-26 null 02 null CISPLATIN + EPIRUBICIN + FLUOROURACIL 100097838
20143370 20180886 null null null 2017-02-21 2017-02-21 ATEZOLIZUMAB + BEVACIZUMAB 02 null ATEZOLIZUMAB + BEVACIZUMAB 100028118
20148182 20180887 null 125.8 Palliative (P) 2020-01-23 2020-01-28 CARBOPLATIN + PACLITAXEL + RT 02 N CARBOPLATIN + PACLITAXEL + RT 101627462
20155475 20180889 null 61.2 null 2021-08-23 2021-08-24 null 02 null EVEROLIMUS 101204404
20157177 20180890 0 62.8 null 2022-05-17 2022-05-20 null 02 null CARBOPLATIN + PACLITAXEL + RT 101243634
20159094 20180891 1.53 57.6 null 2022-03-24 2022-03-26 null 02 null LENALIDOMIDE 101121232
20169180 20180893 1.67 null null 2018-03-18 2018-03-18 null 02 null CAPECITABINE + CETUXIMAB + IRINOTECAN 100813839
20172887 20180895 1.66 78 Adjuvant (A) 2021-12-04 2021-12-18 PEMBROLIZUMAB 02 N PEMBROLIZUMAB 101667430
20180926 20180897 1.55 69 null null 2020-02-03 Bendamustine+Rituximab(Sub Courses) null Y SCOPE2 TRIAL 100350853
20184820 20180899 1.75 79.9 Palliative (P) 2016-08-14 2016-08-22 DARATUMUMAB 02 Y FLUOROURACIL + RT 100129984
20186389 20180900 1.92 63.9 Adjuvant (A) null 2020-08-30 Doce + Pertuzumab + Trastuz IV Maint N null PERTUZUMAB + TRASTUZUMAB 101404371
20194172 20180903 1.6 56 03 2017-12-16 2017-12-29 ECF 02 null DARATUMUMAB 100352389
20197298 20180904 1.6 87.8 Palliative (P) 2021-11-01 2021-12-22 ACELARATE Trial 02 null OXALIPLATIN + MDG + PANITUMUMAB 101227674
20201166 20180905 1.69 89.6 Palliative (P) 2019-06-22 2019-06-23 FEC 02 N TOPOTECAN 100687744
20201314 20180906 1.8 104.9 null 2018-05-03 2018-12-31 DARATUMUMAB Y null ETOPOSIDE + IFOSFAMIDE 101256435
20203204 20180907 1.8 50.8 Palliative (P) 2021-03-21 2021-03-21 CAPE + OXALIPLATIN + TRASTUZUMAB 02 N GEMCARBO 101602500
20206048 20180910 1.64 72.4 Curative (C) 2019-05-25 2020-02-07 Carboplatin + Pemetrexed 02 null BORTEZOMIB + RITUXIMAB 101257517
20206119 20180911 1.8 98.4 Adjuvant (A) 2018-03-08 2018-03-08 Cisplatin + Vinorelbine (PO) 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 100637538
20208450 20180914 1.65 53.2 Palliative (P) 2021-01-05 2021-01-10 FOXTROT TRIAL 02 null PAZOPANIB 101828578
20211578 20180916 1.8 108.3 Palliative (P) 2021-09-14 2021-10-06 TRASTUZUMAB EMTANSINE 01 N TRABECTEDIN 100774675
20213191 20180918 null 69.6 null 2022-03-11 2022-03-13 PACLITAXEL + RAMUCIRUMAB 02 N ALECTINIB 101484197